Who is this course for?
Readers interested in psilocybin therapy, psychedelic research, and the current scientific study of psychedelic-assisted psychotherapy.
This article explains psilocybin therapy and the current research around its use in mental health care. It focuses on how clinical studies are structured, what participants can expect, and the possible benefits and limitations of treatment.
Start date: December 1, 2026
Psilocybin Therapy and the Rise of Existential Medicine examines the renewed scientific interest in psilocybin after decades of limited research. The article draws on a conversation with Dr. Charles Grob to explain how psilocybin therapy is being studied for conditions such as substance use disorder, treatment-resistant depression, and other hard-to-treat psychological conditions. It also describes the typical structure of a psilocybin clinical trial, including screening, preparatory sessions, supervised dosing in a controlled setting, and the use of placebo-controlled, double-blind methods. The piece is intended for readers who want a clear overview of psilocybin-assisted psychotherapy and the practical realities of current research. The content is informational rather than instructional and reflects the legal and scientific limits of access to psilocybin therapy in most places.
Readers interested in psilocybin therapy, psychedelic research, and the current scientific study of psychedelic-assisted psychotherapy.
DoubleBlind is a biannual print magazine and digital media company covering psychedelics and related topics including mental health and environmental justice. Its site says it began as a print magazine and now publishes journalism, offers classes and workshops, and runs a monthly membership programme focused on harm reduction education and community.
View all Double Blind coursesReaders interested in psilocybin therapy, psychedelic research, and the current scientific study of psychedelic-assisted psychotherapy.
Time commitment: 30 days.
The listed price is Price on request. Confirm the latest tuition, fees, and payment options on the provider website.
The listing includes a certificate signal. Accreditation note: CME. Confirm credential eligibility directly with the provider before enrolling.
The listed next cohort date is 2026-12-01.
The current listing status is Active. Use the provider website for the latest enrollment status.
By Alma Institute
Shares course skills and categories
Psychotherapy skill topic focused on courses related to psychedelic therapy, integration, facilitation, ethics, and trauma-informed care. It is used to group courses that cover psychotherapy-adjacent practice and clinical topics.
Next cohort: Dec 1, 2026
By Mind Medicine Australia
Shares course skills and categories
The course is based on the CIIS program, adapted for the Australian context, and with input from MAPS, USONA, and others. It teaches therapists the research, therapy setting, risks, and therapeutic models for working with psychedelics.
Source lists: Estimated 121 hours
Delivery: Online + Australia
By CIIS
Shares course skills and categories
A 12-month certificate in psychedelic-assisted therapies and research housed in the CIIS Center for Psychedelic Therapies and Research. The program offers hybrid or online training covering clinical competencies, research, ethics, and culturally informed approaches.